IDRA: Idera Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
Stocks in this Quantisnow insightHealth Care
Keep researching IDRA
- What is Form 8-K?The SEC "current report" a public company files to disclose material events, generally within four business days of the event.
- Form 8-K explainedWhat a Form 8-K is, when it is due, and what each key item number means, from 1.01 material agreements and 2.02 earnings to 4.02 restatements and 5.02 executive changes.
Quantisnow market dataNASDAQ
IDRA
Idera Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
Get push alerts for IDRA
Full IDRA profile on Quantisnow Follow IDRA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time